// App-Quantinova.ai

614 : Preliminary results from TRASTYVERE study: A retrospective analysis of HER2-positive (HER2) metastatic breast cancer (MBC) patients treated in Spain with lapatinib (L) plus trastuzumab (T).

Researchers

Presenter

  • Joaquin Gavila

Principal Investigators

  • Begoa Bermejo

  • Luis Manso

  • Marta Santisteban

  • Manuel Ruiz Borrego

  • Javier Cortes

  • Joan Brunet

  • Alvaro Rodriguez-Lescure

  • Cesar Augusto Rodriguez

  • Ana Santaballa

  • Pedro Sanchez-Rovira

  • Juan de la Haba-Rodriguez

  • Antonio Llombart-CussacEva Muoz

  • Antonio Anton

Medical Centers

  • Hospital Clinico Universitario, Valencia, Valencia, Spain

  • H. Universitario Miguel Servet, Zaragoza, Spain

  • Hospital Universitario Virgen del Rocio, Sevilla, Spain

  • Medica Scientia Innovation Research, Vall dHebron Institute of Oncology, Barcelona, Spain

  • University Hospital Vall d'Hebron, Barcelona, Spain

  • Hospital General de Elche, Alicante, Spain

  • Medical Oncology. Complejo Hospitalario de Jaen, Jaen, SpainOncology Department, Hospital Universitario de Salamanca, Salamanca, SpainMedical Oncology, Catalan Institute of Oncology and Girona Biomedical Research Institute (IDIBGi), Girona, Spain

  • Medica Scientia Innovation Research (MedSIR), Barcelona, Spain

  • Medical Oncology Department. Hospital 12 de Octubre, Madrid, Spain

  • Hospital Universitari I Politecnic La Fe, Valencia, Spain

  • Department of Pathology, University of Navarra, Pamplona, Spain

  • Instiuto Valenciano de Oncologia, Valencia, Spain

  • Medical Oncology Department University Reina Sofia Hospital. Biomedical Research Institute Maimonides, Cordoba, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Brain metastasis

  • Solid malignancies

Biomarkers

  • Phosphatase and tensin homolog

  • Human epidermal growth factor receptor 2

  • Hormone receptor

Drug/Treatment

  • Trastuzumab

  • Lapatinib

Outcome

  • Positive

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved